These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8385627)

  • 1. Schistosoma mansoni: an enkephalinergic system that may participate in internal and host-parasite signaling.
    Duvaux-Miret O; Leung MK; Capron A; Stefano GB
    Exp Parasitol; 1993 Feb; 76(1):76-84. PubMed ID: 8385627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible role for an enkephalinergic system in the internal defense mechanism of Biomphalaria alexandrina exposed to Schistosoma mansoni.
    Osman AM; Gomma M; Saad AH
    J Egypt Soc Parasitol; 2003 Dec; 33(3):841-61. PubMed ID: 14708857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of multiple morphine and enkephalin binding sites in the central nervous system.
    Wolozin BL; Pasternak GW
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6181-5. PubMed ID: 6273857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zeta (zeta), a growth-related opioid receptor in developing rat cerebellum: identification and characterization.
    Zagon IS; Gibo DM; McLaughlin PJ
    Brain Res; 1991 Jun; 551(1-2):28-35. PubMed ID: 1655161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of rat brain opioid receptors by [Tyr-3,5-3H]1, D-Ala2, Leu5-enkephalin binding.
    Benyhe S; Tóth G; Kevei J; Szücs M; Borsodi A; Di Gléria K; Szécsi J; Süli-Vargha H; Medzihradszky K
    Neurochem Res; 1985 May; 10(5):627-35. PubMed ID: 2989719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve growth factor induces specific enkephalin binding sites in a nerve cell line.
    Inoue N; Hatanaka H
    J Biol Chem; 1982 Aug; 257(16):9238-41. PubMed ID: 6286607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential modification of opiate receptor activity by arylsulfatase treatment.
    Garzón J; Jen MF; Lee NM
    Biochem Pharmacol; 1983 May; 32(9):1523-8. PubMed ID: 6134534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody to enkephalins with binding characteristics similar to opiate receptor.
    Deguchi T; Yokoyama E
    Biochem Biophys Res Commun; 1985 Jan; 126(1):389-96. PubMed ID: 2857562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of naloxone to human T lymphocytes.
    Madden JJ; Donahoe RM; Zwemer-Collins J; Shafer DA; Falek A
    Biochem Pharmacol; 1987 Dec; 36(23):4103-9. PubMed ID: 2825715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of delta opioid binding sites in the bovine pineal.
    Aloyo VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):292-7. PubMed ID: 1320688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid peptides in the nervous system of Aplysia: a combined biochemical, immunocytochemical, and electrophysiological study.
    Carpenter DO; Kemenes G; Elekes K; Leung M; Stefano G; Rózsa KS; Salánki J
    Cell Mol Neurobiol; 1995 Apr; 15(2):239-56. PubMed ID: 8590454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodinated [D-Ala2, Met5] enkephalin. Preparation, purification by high performance liquid chromatography and binding characteristics.
    Yeung CW
    Int J Pept Protein Res; 1984 Dec; 24(6):636-44. PubMed ID: 6099338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of zeta (zeta): a new opioid receptor involved in growth.
    Zagon IS; Goodman SR; McLaughlin PJ
    Brain Res; 1989 Mar; 482(2):297-305. PubMed ID: 2539884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enkephalins have a direct positive inotropic effect on cultured cardiac myocytes.
    Laurent S; Marsh JD; Smith TW
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5930-4. PubMed ID: 2994054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA; Lutz RA; Munson PJ; Rodbard D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression in the definitive and intermediate hosts of the human parasite Schistosoma mansoni by release of immunoactive neuropeptides.
    Duvaux-Miret O; Stefano GB; Smith EM; Dissous C; Capron A
    Proc Natl Acad Sci U S A; 1992 Jan; 89(2):778-81. PubMed ID: 1309957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metkephamid (Tyr-D-ala-Gly-Phe-N(Me)Met-NH2), a potent opioid peptide: receptor binding and analgesic properties.
    Burkhardt C; Frederickson RC; Pasternak GW
    Peptides; 1982; 3(5):869-71. PubMed ID: 6294639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding characteristics of [3H]opioid ligands to active opioid binding sites solubilized from rat brain membranes by glycodeoxycholate and NaCl: the recovery of binding activity by dilution.
    Maruyama M; Sugino H; Akita K; Hatanaka H
    Brain Res; 1987 Jan; 401(1):14-22. PubMed ID: 2880641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The opiate receptor binding interactions of 3H-methionine enkephalin, an opioid peptide.
    Simantov R; Childers SR; Snyder SH
    Eur J Pharmacol; 1978 Feb; 47(3):319-31. PubMed ID: 204498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.